Vir Biotechnology, Inc. (VIR)
USD 6.16
(1.32%)
USD 6.16
(1.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 83.41 Million USD | -95.54% |
| 2022 | 1.43 Billion USD | 40.44% |
| 2021 | 1.02 Billion USD | 535.79% |
| 2020 | -234.33 Million USD | -58.59% |
| 2019 | -147.76 Million USD | -48.71% |
| 2018 | -99.36 Million USD | -59.33% |
| 2017 | -62.36 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -1.23 Million USD | -102.39% |
| 2024 Q3 | 2.33 Million USD | 288.36% |
| 2024 Q1 | 51.8 Million USD | 350.04% |
| 2023 Q2 | -12.74 Million USD | -128.44% |
| 2023 FY | 63.96 Million USD | -95.54% |
| 2023 Q4 | 11.51 Million USD | 378.29% |
| 2023 Q3 | -4.13 Million USD | 67.55% |
| 2023 Q1 | 44.8 Million USD | 183.7% |
| 2022 Q3 | 349.17 Million USD | 594.53% |
| 2022 Q2 | -70.6 Million USD | -106.19% |
| 2022 Q1 | 1.13 Billion USD | 51.39% |
| 2022 FY | 1.43 Billion USD | 40.44% |
| 2022 Q4 | 15.79 Million USD | -95.48% |
| 2021 FY | 1.02 Billion USD | 535.79% |
| 2021 Q4 | 752.87 Million USD | 693.53% |
| 2021 Q3 | 94.87 Million USD | -45.11% |
| 2021 Q2 | 172.84 Million USD | 228.73% |
| 2021 Q1 | -134.26 Million USD | -175813267.82% |
| 2020 Q3 | -70.49 Million USD | -426.72% |
| 2020 Q2 | -13.38 Million USD | 76.65% |
| 2020 FY | -234.33 Million USD | -58.59% |
| 2020 Q1 | -57.32 Million USD | -7.4% |
| 2020 Q4 | 76.37 USD | 100.0% |
| 2019 Q3 | -39.62 Million USD | -33.34% |
| 2019 FY | -147.76 Million USD | -48.71% |
| 2019 Q1 | -25.85 Million USD | -8.56% |
| 2019 Q4 | -53.37 Million USD | -34.71% |
| 2019 Q2 | -29.71 Million USD | -14.94% |
| 2018 Q4 | -23.81 Million USD | 19.87% |
| 2018 Q1 | -20.86 Million USD | 0.0% |
| 2018 FY | -99.36 Million USD | -59.33% |
| 2018 Q2 | -20.86 Million USD | 0.0% |
| 2018 Q3 | -29.72 Million USD | -42.45% |
| 2017 FY | -62.36 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 284.038% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 178.602% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -296.064% |
| Autolus Therapeutics plc | -4.86 Million USD | 1813.889% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2309485.382% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 10089.82% |
| Shattuck Labs, Inc. | -2.38 Million USD | 3597.484% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 3565.517% |
| CervoMed Inc. | -1.29 Million USD | 6548.149% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1275.19% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 367.633% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 17677.89% |
| Precision BioSciences, Inc. | 40.47 Million USD | -106.105% |
| Dyadic International, Inc. | 922.95 Thousand USD | -8937.799% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 224.307% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 56844.898% |
| Nektar Therapeutics | 53.47 Million USD | -55.98% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 15.776% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -19573.349% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -101.554% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 19635.129% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 11.938% |
| GRI Bio, Inc. | 10.84 Million USD | -669.44% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -3184.073% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1060.228% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 86094.845% |
| Psyence Biomedical Ltd. | -240.00 USD | 34756350.0% |
| IGM Biosciences, Inc. | -211.66 Million USD | 139.41% |
| INmune Bio, Inc. | 155 Thousand USD | -53716.129% |
| Opthea Limited | 21.72 Thousand USD | -383946.961% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -20650.0% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 232.879% |
| Verastem, Inc. | -62 Thousand USD | 134640.323% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -3325.667% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 32059.77% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -2655.699% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 30.344% |
| NextCure, Inc. | -3.68 Million USD | 2364.251% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 724.464% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1647.875% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 71.8 Million USD | -16.177% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 7023.096% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -315.993% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 10247.81% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1275.028% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 46.111% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 184.929% |
| Senti Biosciences, Inc. | -2.68 Million USD | 3209.02% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -57111.934% |
| Apollomics, Inc. | 127 Thousand USD | -65581.102% |
| PureTech Health plc | -1.6 Million USD | 5303.681% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 387.956% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -10300.873% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 175.496% |
| Synaptogenix, Inc. | -6347.00 USD | 1314342.949% |
| ChromaDex Corporation | 50.78 Million USD | -64.267% |
| Beam Therapeutics Inc. | -59.67 Million USD | 239.789% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 30.761% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 174.371% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 75.327% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1432.508% |
| Mesoblast Limited | -9.81 Million USD | 949.873% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 38.334% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 184.976% |
| MediWound Ltd. | 3.57 Million USD | -2231.33% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -69412.5% |
| Fortress Biotech, Inc. | 57.85 Million USD | -44.184% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -193888.372% |
| Achilles Therapeutics plc | -4.73 Million USD | 1863.058% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 33.598% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 291.922% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 362773.913% |
| Zai Lab Limited | 170.9 Million USD | 51.192% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -941.906% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -64065.385% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 53.097% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -426.145% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.194% |
| FibroGen, Inc. | 128.9 Million USD | 35.289% |
| Celcuity Inc. | -142.77 Thousand USD | 58525.321% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| ContextLogic Inc. | 59 Million USD | -41.381% |
| GH Research PLC | -315 Thousand USD | 26580.952% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -403.197% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -21343.445% |
| ImmuCell Corporation | 4.39 Million USD | -1797.398% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 76.526% |
| Amarin Corporation plc | 165.54 Million USD | 49.611% |
| TG Therapeutics, Inc. | 219.1 Million USD | 61.93% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 14811.64% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 7628.43% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 210.434% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -13.64% |
| Aptorum Group Limited | -1.11 Million USD | 7583.26% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 78.559% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 74.471% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 124922.302% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 65.35% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 16242.36% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 2449.057% |
| Ardelyx, Inc. | 106.66 Million USD | 21.794% |
| Ainos, Inc. | -253.73 Thousand USD | 32975.109% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 279.499% |
| Prothena Corporation plc | -129.2 Million USD | 164.562% |
| HilleVax, Inc. | -2.15 Million USD | 3968.97% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -65.427% |
| Celularity Inc. | 6.75 Million USD | -1134.863% |
| Rallybio Corporation | -150 Thousand USD | 55710.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 355.819% |
| Omeros Corporation | -69.77 Million USD | 219.542% |
| Humacyte, Inc. | -76.55 Million USD | 208.968% |
| Immunocore Holdings plc | 248.39 Million USD | 66.418% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 649.904% |
| Blueprint Medicines Corporation | 236.58 Million USD | 64.742% |
| IO Biotech, Inc. | -756 Thousand USD | 11133.73% |
| MEI Pharma, Inc. | 49.32 Million USD | -69.106% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 5949.579% |
| Summit Therapeutics Inc. | -2.05 Million USD | 4169.024% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1838.537% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -187.093% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3033.017% |
| Pulmatrix, Inc. | -8.22 Million USD | 1114.781% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 7229.487% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 4279.108% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 21006.015% |
| Acelyrin, Inc. | -115 Thousand USD | 72634.783% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 120.917% |
| Cytokinetics, Incorporated | -322.59 Million USD | 125.858% |
| Vor Biopharma Inc. | -3.49 Million USD | 2488.746% |
| Evogene Ltd. | 1.39 Million USD | -5862.473% |
| Replimune Group, Inc. | -2.65 Million USD | 3241.808% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 289.959% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 145609.891% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1116.494% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -7428.43% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 252872.727% |
| Atai Life Sciences N.V. | -5000.00 USD | 1668400.0% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 86990.625% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -16717.54% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 6105.4% |
| Sagimet Biosciences Inc. | 2 Million USD | -4070.75% |
| MediciNova, Inc. | 979.7 Thousand USD | -8414.298% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 198.928% |
| MiMedx Group, Inc. | 266.84 Million USD | 68.74% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 88318.497% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 65.888% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 90.438% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1023.283% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 695225.0% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1668400.0% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 3489.476% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 1458.329% |
| scPharmaceuticals Inc. | 9.78 Million USD | -752.74% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 220.898% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 82.472% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 731297.405% |
| Precigen, Inc. | 106 Thousand USD | -78593.396% |
| XOMA Corporation | 3.86 Million USD | -2060.451% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 219.02% |
| Incyte Corporation | 3.44 Billion USD | 97.576% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 164496.926% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -463.843% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -569.462% |
| Seer, Inc. | 7.02 Million USD | -1087.064% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 65.382% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 287737.931% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -641653746.154% |
| Akari Therapeutics, Plc | -4000.00 USD | 2085475.0% |
| Novavax, Inc. | 639.93 Million USD | 86.965% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -42741.075% |
| UroGen Pharma Ltd. | 73.35 Million USD | -13.719% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 412.486% |
| Entera Bio Ltd. | -56 Thousand USD | 149055.357% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 44234.921% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -1959.121% |
| Chimerix, Inc. | 324 Thousand USD | -25645.37% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 15988.571% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -16097.087% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 188872.97% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 97.546% |
| AnaptysBio, Inc. | 14.78 Million USD | -464.339% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -14377.272% |
| Portage Biotech Inc. | -54 Thousand USD | 154572.222% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 22225.995% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 6736.038% |
| OKYO Pharma Limited | -7506.16 USD | 1111387.263% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1855828.587% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 4212978.788% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 37574424.324% |
| AbCellera Biologics Inc. | 38.02 Million USD | -119.369% |
| Genprex, Inc. | -15 Thousand USD | 556051.746% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 12587.275% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 731297.405% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 2.76 Million USD | -2911.892% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 4924.465% |
| Bicycle Therapeutics plc | -129.52 Million USD | 164.403% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 120.871% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -47.148% |
| Erasca, Inc. | -3.73 Million USD | 2335.129% |
| bluebird bio, Inc. | -4.03 Million USD | 2169.851% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -8167.096% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 95.62% |
| DBV Technologies S.A. | 15.72 Million USD | -430.36% |
| Fortress Biotech, Inc. | 57.85 Million USD | -44.184% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 145.982% |
| CorMedix Inc. | -205.56 Thousand USD | 40678.998% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 37.651% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 14708.581% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -3140.676% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 312.02% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 175.062% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -241.152% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 2424.833% |
| Onconetix, Inc. | -1.12 Million USD | 7500.425% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -338.035% |
| Prime Medicine, Inc. | -147.9 Million USD | 156.398% |
| Adagene Inc. | 18.11 Million USD | -360.564% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -13597.044% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 58309.643% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 40.504% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 148.164% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 47.151% |
| SciSparc Ltd. | 2.19 Million USD | -3698.497% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 333107.306% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 269336.976% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 13.441% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -52.722% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1273.924% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 94.505% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 15.132% |
| ADMA Biologics, Inc. | 88.21 Million USD | 5.444% |
| Clene Inc. | 533 Thousand USD | -15550.094% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -245.988% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 8816.301% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -4095.926% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 43027.5% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -67.483% |
| Absci Corporation | -41.84 Million USD | 299.324% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.262% |
| Surrozen, Inc. | -27.23 Million USD | 406.335% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 207.496% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 278.089% |
| Cingulate Inc. | -582.91 Thousand USD | 14409.903% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 269180.645% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1102015.456% |
| Jaguar Health, Inc. | 7.72 Million USD | -979.946% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 9568.218% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 87.746% |
| Kronos Bio, Inc. | 1.37 Million USD | -5979.81% |
| Innoviva, Inc. | 261.06 Million USD | 68.048% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 255.434% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -186.364% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 802167.308% |
| Soligenix, Inc. | 97.31 Thousand USD | -85620.011% |
| AlloVir, Inc. | -398 Thousand USD | 21058.543% |
| Century Therapeutics, Inc. | -10.8 Million USD | 871.718% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 8182.849% |
| Kura Oncology, Inc. | -849 Thousand USD | 9925.088% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 49751.786% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -34.673% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 5637.775% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 12963.673% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 285045.686% |
| HCW Biologics Inc. | -574.82 Thousand USD | 14611.398% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 186.039% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 26750.16% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 11.694% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 47808.516% |
| Histogen Inc. | 3.76 Million USD | -2113.187% |
| Surrozen, Inc. | -27.23 Million USD | 406.335% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 22403.476% |
| Kodiak Sciences Inc. | -25.94 Million USD | 421.482% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 634048.928% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 124357.05% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 4180.969% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -12933.594% |
| Moderna, Inc. | 2.15 Billion USD | 96.129% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 89.285% |
| Turnstone Biologics Corp. | 16.5 Million USD | -405.362% |
| Immix Biopharma, Inc. | -5468.00 USD | 1525612.07% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 163658.824% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 48.307% |
| Exelixis, Inc. | 1.75 Billion USD | 95.254% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1440.646% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 19.87% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 93.932% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 7628.43% |
| Arcellx, Inc. | 108.27 Million USD | 22.963% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 70497.752% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1039.86% |
| Insmed Incorporated | 239.63 Million USD | 65.191% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 357.7% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -5.317% |
| Moolec Science SA | -143.3 Thousand USD | 58308.018% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 297.115% |
| Geron Corporation | -123.5 Million USD | 167.541% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -2437.724% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1805.322% |
| Royalty Pharma plc | 1.79 Billion USD | 95.35% |
| OmniAb, Inc. | 14.66 Million USD | -468.726% |
| Alector, Inc. | -95.05 Million USD | 187.756% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 219.011% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 174.869% |
| Humacyte, Inc. | -76.55 Million USD | 208.968% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 8888.167% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -1.878% |
| 89bio, Inc. | -273 Thousand USD | 30654.945% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | -1.29 Million USD | 6541.313% |
| Immunic, Inc. | -111 Thousand USD | 75248.649% |
| Veracyte, Inc. | 248.14 Million USD | 66.385% |
| Genelux Corporation | -848 Thousand USD | 9936.675% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 67917.073% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 14789993.617% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 814.972% |
| Immunovant, Inc. | -231 Thousand USD | 36210.39% |
| Vericel Corporation | 135.57 Million USD | 38.474% |
| Fortrea Holdings Inc. | 424 Million USD | 80.327% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 196.806% |
| XBiotech Inc. | -1.74 Million USD | 4882.97% |
| Agenus Inc. | 139.61 Million USD | 40.254% |
| Acasti Pharma Inc. | -11 Thousand USD | 758418.182% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2171.374% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 40866.407% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 12963.673% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -396.429% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 268.016% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 836.632% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 21993.701% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 479.383% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -22.442% |
| United Therapeutics Corporation | 2.07 Billion USD | 95.97% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1544622.222% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 101107.471% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -125782.832% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2216.032% |
| Pharming Group N.V. | 220.1 Million USD | 62.102% |
| XOMA Corporation | 3.86 Million USD | -2060.451% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 19300.182% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 7866.76% |
| Pyxis Oncology, Inc. | -2 Million USD | 4270.75% |
| uniQure N.V. | 2.21 Million USD | -3665.914% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 4490.263% |
| Cassava Sciences, Inc. | -89.42 Million USD | 193.281% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 37848.272% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 101825.61% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 190.601% |
| Pluri Inc. | 322 Thousand USD | -25805.28% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 287 Thousand USD | -28964.46% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -33.716% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 898.615% |
| CalciMedica, Inc. | -58 Thousand USD | 143918.966% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 370.258% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 76.959% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 830017.421% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 7866.76% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -2905.312% |
| Nutriband Inc. | 862.1 Thousand USD | -9575.736% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 24561.877% |
| Compugen Ltd. | 31.45 Million USD | -165.188% |
| Roivant Sciences Ltd. | 109.23 Million USD | 23.637% |
| ProKidney Corp. | -3.16 Million USD | 2732.218% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 295709.186% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -7252.06% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 206.03% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 68552.063% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -240.247% |
| Benitec Biopharma Inc. | 108 Thousand USD | -77136.111% |
| GeoVax Labs, Inc. | -20.72 Million USD | 502.567% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2085.599% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 27008.065% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 209.221% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 60.973% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 464.305% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 107042.308% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 8964.506% |
| Imunon, Inc. | -720 Thousand USD | 11685.336% |
| BioAtla, Inc. | -103.73 Million USD | 180.415% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 134.353% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 26921.543% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | -2.38 Million USD | 3593.09% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 15928.273% |
| Viridian Therapeutics, Inc. | -1 Million USD | 8375.298% |
| Galecto, Inc. | -830 Thousand USD | 10150.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 86.903% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -7354.424% |
| PolyPid Ltd. | -1.82 Million USD | 4678.211% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 70196.639% |
| Forte Biosciences, Inc. | -9000.00 USD | 926933.333% |
| Xencor, Inc. | -85.26 Million USD | 197.836% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 8431.203% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -42741.075% |
| Instil Bio, Inc. | -4.75 Million USD | 1853.89% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 88318.497% |
| OncoCyte Corporation | 413 Thousand USD | -20097.337% |
| Elevation Oncology, Inc. | -39 Thousand USD | 213984.615% |
| Purple Biotech Ltd. | -196 Thousand USD | 42658.673% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -830.14% |
| MacroGenics, Inc. | 50.52 Million USD | -65.09% |
| Verona Pharma plc | -679.62 Thousand USD | 12373.698% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 47765.714% |
| Aditxt, Inc. | -111.66 Thousand USD | 74804.46% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | -44.26 Million USD | 288.457% |
| Curis, Inc. | 9.81 Million USD | -750.219% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 66945.37% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 36685.526% |
| BeiGene, Ltd. | 2.07 Billion USD | 95.987% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 295709.186% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 9216.393% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1846.18% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 15662.5% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 24.011% |
| Adicet Bio, Inc. | -6.09 Million USD | 1467.908% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -16993.238% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | -73.91 Million USD | 212.859% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 19188.101% |
| Invivyd, Inc. | -2.02 Million USD | 4213.166% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 127.727% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 80742.51% |
| Moolec Science SA | -143.3 Thousand USD | 58308.018% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -959.776% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1668400.0% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 10077.871% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -113992.078% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -56.907% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 23730.312% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 523.448% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 8542.814% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 148151.187% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -287.166% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 73.407% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 28666.781% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 12662.5% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -1978.619% |
| ImmunityBio, Inc. | -17.89 Million USD | 566.266% |
| Korro Bio, Inc. | -3.63 Million USD | 2397.934% |
| Kineta, Inc. | 5.43 Million USD | -1435.34% |
| BioVie Inc. | -229.37 Thousand USD | 36465.895% |
| Codexis, Inc. | 57.33 Million USD | -45.49% |
| Celularity Inc. | 6.75 Million USD | -1134.863% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -164784.364% |
| Cibus, Inc. | 1.42 Million USD | -5766.034% |
| Annexon, Inc. | -3.26 Million USD | 2653.26% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 299.859% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 51.771% |
| NeurAxis, Inc. | 2.15 Million USD | -3767.707% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 494.36% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 4513.492% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -35949.371% |
| Notable Labs, Ltd. | 113 Thousand USD | -73718.584% |
| IN8bio, Inc. | -2.5 Million USD | 3435.266% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 278150.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -4379.86% |
| Lumos Pharma, Inc. | 2 Million USD | -4056.203% |
| Liquidia Corporation | 14.6 Million USD | -471.336% |
| Mustang Bio, Inc. | -2.22 Million USD | 3848.989% |
| Quantum-Si incorporated | 488 Thousand USD | -16993.238% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 250.138% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 47765.714% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 516.326% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 79035.415% |
| Vaxcyte, Inc. | -75 Million USD | 211.22% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 149.796% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 7033.915% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -163.482% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 4360.215% |
| PepGen Inc. | -1.18 Million USD | 7145.186% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 65781.102% |
| Solid Biosciences Inc. | -76.56 Million USD | 208.949% |
| Palisade Bio, Inc. | 246 Thousand USD | -33808.537% |
| Nutriband Inc. | 862.1 Thousand USD | -9575.736% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 11016.222% |
| Belite Bio, Inc | -399 Thousand USD | 21006.015% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 283.136% |
| GeoVax Labs, Inc. | -20.72 Million USD | 502.567% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 252872.727% |
| Altimmune, Inc. | -65.37 Million USD | 227.599% |
| Peak Bio, Inc. | 367.76 Thousand USD | -22581.357% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 19188.101% |
| Neurogene Inc. | -3.26 Million USD | 2657.174% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 40.133% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 151763.636% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 2359.345% |
| Sesen Bio, Inc. | 40 Million USD | -108.538% |
| argenx SE | 1.1 Billion USD | 92.475% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 7033.915% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -3275.759% |
| Immunome, Inc. | -8.9 Million USD | 1036.511% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 20543.35% |
| Design Therapeutics, Inc. | -537 Thousand USD | 15633.52% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -3786.999% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 28185.859% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 971.995% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -492.436% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 3222.37% |
| Athira Pharma, Inc. | -969 Thousand USD | 8708.359% |
| XOMA Corporation | 3.86 Million USD | -2060.451% |
| Merus N.V. | -83.46 Million USD | 199.945% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 26005.28% |
| Rezolute, Inc. | -36 Thousand USD | 231808.333% |
| Clene Inc. | 533 Thousand USD | -15550.094% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 6496595.327% |
| BeyondSpring Inc. | 1.75 Million USD | -4663.849% |
| Synlogic, Inc. | -1.92 Million USD | 4435.499% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 225545.946% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1417.356% |
| Peak Bio, Inc. | 367.76 Thousand USD | -22581.357% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 539.883% |
| Krystal Biotech, Inc. | 47.6 Million USD | -75.223% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 40.879% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1560.0% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 3321.628% |
| MannKind Corporation | 136.19 Million USD | 38.751% |
| Ikena Oncology, Inc. | -50.49 Million USD | 265.204% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 23.342% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2002.281% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 33201.19% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1668400.0% |
| Legend Biotech Corporation | 140.92 Million USD | 40.811% |
| Mural Oncology plc | -2.56 Million USD | 3349.513% |
| Disc Medicine, Inc. | -100 Thousand USD | 83515.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -301.923% |
| REGENXBIO Inc. | 53.02 Million USD | -57.301% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1657.135% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 43460.624% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 4916.109% |
| Vaxart, Inc. | -60.76 Million USD | 237.279% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 31843.283% |
| Cellectis S.A. | 18 Thousand USD | -463316.667% |
| Longeveron Inc. | 221 Thousand USD | -37644.344% |
| Repare Therapeutics Inc. | -80.07 Million USD | 204.178% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 92.368% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 6546.291% |
| Revolution Medicines, Inc. | -399.66 Million USD | 120.871% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 238428.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -170134.694% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.031% |
| Denali Therapeutics Inc. | -93.34 Million USD | 189.362% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 333107.306% |
| Veru Inc. | 7.56 Million USD | -1002.509% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 55341.722% |
| Cingulate Inc. | -582.91 Thousand USD | 14409.903% |
| Passage Bio, Inc. | -3.72 Million USD | 2341.736% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 692685.52% |
| Exicure, Inc. | -1.42 Million USD | 5961.911% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 21879.373% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -2986.016% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 16370.542% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 55856.081% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 240.889% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -21233.76% |
| OmniAb, Inc. | 14.66 Million USD | -468.726% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -317.221% |
| Lipocine Inc. | -2.85 Million USD | 3026.002% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 4626.044% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1562.138% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 5637.775% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -10.753% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 128430.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 1.045% |
| Ocugen, Inc. | -33.53 Million USD | 348.725% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 2738.046% |
| Q32 Bio Inc. | 578 Thousand USD | -14331.661% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 31577.358% |
| Alumis Inc. Common Stock | -1.28 Million USD | 6596.495% |
| Equillium, Inc. | 35.95 Million USD | -131.979% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 4986.643% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -16560.375% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2017879.39% |
| Dominari Holdings Inc. | 2.03 Million USD | -3990.976% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 45564.951% |
| vTv Therapeutics Inc. | -13.59 Million USD | 713.571% |
| Bio-Techne Corporation | 773.07 Million USD | 89.21% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -381.639% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 81.897% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 7235.586% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 447.852% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -613.132% |
| Nkarta, Inc. | -5.86 Million USD | 1521.281% |
| BioCardia, Inc. | -7.24 Million USD | 1250.71% |
| Iterum Therapeutics plc | -1.75 Million USD | 4866.571% |